These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9448591)

  • 1. Decrease of interleukin 6 during the first 12 months is a prognostic marker for clinical outcome during 36 months treatment with disease-modifying anti-rheumatic drugs.
    Straub RH; Müller-Ladner U; Lichtinger T; Schölmerich J; Menninger H; Lang B
    Br J Rheumatol; 1997 Dec; 36(12):1298-303. PubMed ID: 9448591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of plasma IL-6 but not TNF-α by methotrexate in patients with early rheumatoid arthritis: a potential biomarker for radiographic progression.
    Nishina N; Kaneko Y; Kameda H; Kuwana M; Takeuchi T
    Clin Rheumatol; 2013 Nov; 32(11):1661-6. PubMed ID: 23754245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different monocyte reaction patterns in newly diagnosed, untreated rheumatoid arthritis and lupus patients probably confer disparate C-reactive protein levels.
    Liou LB
    Clin Exp Rheumatol; 2003; 21(4):437-44. PubMed ID: 12942694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of IL-37 and correlation with TNF-α, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis.
    Zhao PW; Jiang WG; Wang L; Jiang ZY; Shan YX; Jiang YF
    PLoS One; 2014; 9(5):e95346. PubMed ID: 24788826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M; Zwicker M; Villiger PM
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of rheumatoid arthritis following adjunct statin therapy.
    Das S; Mohanty M; Padhan P
    Indian J Pharmacol; 2015; 47(6):605-9. PubMed ID: 26729950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis.
    Jonsson MK; Sundlisæter NP; Nordal HH; Hammer HB; Aga AB; Olsen IC; Brokstad KA; van der Heijde D; Kvien TK; Fevang BS; Lillegraven S; Haavardsholm EA
    Ann Rheum Dis; 2017 Dec; 76(12):2031-2037. PubMed ID: 28814431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prothrombotic biomarkers in patients with rheumatoid arthritis: the beneficial effect of IL-6 receptor blockade.
    Gualtierotti R; Ingegnoli F; Griffini S; Grovetti E; Meroni PL; Cugno M
    Clin Exp Rheumatol; 2016; 34(3):451-8. PubMed ID: 27086948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker.
    Hwang YG; Balasubramani GK; Metes ID; Levesque MC; Bridges SL; Moreland LW
    Arthritis Res Ther; 2016 May; 18(1):108. PubMed ID: 27188329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can tocilizumab decrease cartilage oligomeric matrix protein levels and disease activity in patients with long-standing rheumatoid arthritis?
    Benucci M; Meacci F; Manfredi M; Gobbi FL; Infantino M; Ricci C; Sarzi-Puttini P; Atzeni F
    Curr Rheumatol Rev; 2014; 10(2):131-5. PubMed ID: 25599685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses.
    Aletaha D; Smolen JS
    Rheumatology (Oxford); 2002 Dec; 41(12):1367-74. PubMed ID: 12468815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of response to TNF-α antagonist therapy in Chinese rheumatoid arthritis.
    Ding R; Li P; Song D; Zhang X; Bi L
    Clin Rheumatol; 2015 Jul; 34(7):1203-10. PubMed ID: 25990005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of circulating interleukin-6 concentrations is associated with decreased endothelial activation in rheumatoid arthritis.
    Dessein PH; Joffe BI
    Clin Exp Rheumatol; 2006; 24(2):161-7. PubMed ID: 16762151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and in vitro production of IL-1 receptor antagonist correlate with C-reactive protein levels in newly diagnosed, untreated lupus patients.
    Liou LB
    Clin Exp Rheumatol; 2001; 19(5):515-23. PubMed ID: 11579710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can Cytokines be used as an Activation Marker in Rheumatoid Arthritis?
    Kaya FÖ; Ceylan Y; İpek BÖ; Özünal ZG; Sezgin G; Nalbant S
    Endocr Metab Immune Disord Drug Targets; 2021; 21(8):1459-1465. PubMed ID: 33076814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of radiographic changes in the temporomandibular joints of patients with rheumatoid arthritis in relation to inflammatory markers and mediators in the blood.
    Voog U; Alstergren P; Eliasson S; Leibur E; Kallikorm R; Kopp S
    Acta Odontol Scand; 2004 Feb; 62(1):7-13. PubMed ID: 15124777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor blockade differentially affects innate inflammatory and Th17 cytokines in rheumatoid arthritis.
    Zivojinovic SM; Pejnovic NN; Sefik-Bukilica MN; Kovacevic LV; Soldatovic II; Damjanov NS
    J Rheumatol; 2012 Jan; 39(1):18-21. PubMed ID: 22133625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Measurement of inflammatory cytokines in patients with rheumatoid arthritis].
    Kang SY; Kim MH; Lee WI
    Korean J Lab Med; 2010 Jun; 30(3):301-6. PubMed ID: 20603592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of gold salts treatment on the serum concentration of IL-1 and IL-2 in patients with rheumatoid arthritis.
    Lewandowicz J; Dabkowska B; Nowak D
    Arch Immunol Ther Exp (Warsz); 1995; 43(3-4):195-8. PubMed ID: 8744695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab.
    Nordal HH; Brun JG; Hordvik M; Eidsheim M; Jonsson R; Halse AK
    Scand J Rheumatol; 2016 Jul; 45(4):274-81. PubMed ID: 26767827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.